{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:47Z","timestamp":1792806167771,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04423-4","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:39:00Z","timestamp":1780411140000},"page":"5167-5172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Geographic equity in oncology clinical trials in Spain: fragmentation, indicators, and evidence"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7922-5231","authenticated-orcid":false,"given":"Antonio David L\u00e1zaro","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier David Ben\u00edtez","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Garc\u00eda Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Garc\u00eda-Foncillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"de Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Lorenzo Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma","family":"Pacheco-Barcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"4423_CR1","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). The REec reaches 10,000 clinical trials published. Published October 23, 2024. Accessed January 20, 2026."},{"key":"4423_CR2","unstructured":"Instituto Nacional de Estad\u00edstica (INE). Defunciones por causas (lista reducida) por comunidad aut\u00f3noma (t=10803). Accessed January 20, 2026. https:\/\/www.ine.es\/jaxiT3\/Tabla.htm?t=10803"},{"key":"4423_CR3","unstructured":"Observatorio de la Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC). Informe din\u00e1mico: incidencia. Accessed January 20, 2026. https:\/\/observatorio.contraelcancer.es\/informes\/informe-dinamico-incidencia"},{"key":"4423_CR4","unstructured":"Registro Espa\u00f1ol de Estudios Cl\u00ednicos (REec). Advanced search. Accessed January 20, 2026. https:\/\/reec.aemps.es\/reec\/public\/advancedsearch.html"},{"key":"4423_CR5","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Servicios de consulta de estudios publicados en REec. Published March 4, 2024. Accessed January 20, 2026. https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/investigacion_medicamentos\/ensayosclinicos\/servicios-de-consulta-de-estudios-publicados-en-reec\/"},{"key":"4423_CR6","unstructured":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC). Comprometidos con la investigaci\u00f3n en c\u00e1ncer 2 (2016\u20132020). Accessed January 20, 2026. https:\/\/observatorio.contraelcancer.es\/sites\/default\/files\/informes\/Comprometidos%20con%20la%20investigacion%20en%20Cancer%202%20FINAL.pdf"},{"key":"4423_CR7","unstructured":"Ministerio de Sanidad (Spain); European Cancer Inequalities Registry. National Cancer Profiles 2025: Spain. Madrid, Spain: Ministerio de Sanidad; 2025. Accessed January 20, 2026. https:\/\/www.sanidad.gob.es\/areas\/calidadAsistencial\/estrategias\/cancer\/docs\/PERFILES_NACIONALES_DE_CANCER_2025_ESPANA.pdf"},{"issue":"3","key":"4423_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100515","volume":"7","author":"G Tini","year":"2022","unstructured":"Tini G, Trapani D, Duso BA, Beria P, Curigliano G, Pelicci PG, et al. Quantifying geographical accessibility to cancer clinical trials in different income landscapes. ESMO Open. 2022;7(3):100515. https:\/\/doi.org\/10.1016\/j.esmoop.2022.100515. (Epub 2022 Jun 21. PMID: 35738201; PMCID: PMC9271515.).","journal-title":"ESMO Open"},{"issue":"4","key":"4423_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101610","volume":"8","author":"E Charton","year":"2023","unstructured":"Charton E, Baldini C, Fayet Y, Schultz E, Auroy L, Vallier E, et al. Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study. ESMO Open. 2023;8(4):101610. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101610. (Epub 2023 Aug 1. PMID: 37536254; PMCID: PMC10415590.).","journal-title":"ESMO Open"},{"issue":"3","key":"4423_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/jnci\/djaa155","volume":"113","author":"JM Unger","year":"2021","unstructured":"Unger JM, Hershman DL, Till C, Minasian LM, Osarogiagbon RU, Fleury ME, et al. When offered to participate\": a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. J Natl Cancer Inst. 2021;113(3):244\u201357. https:\/\/doi.org\/10.1093\/jnci\/djaa155.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"4423_CR11","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1634\/theoncologist.2017-0628","volume":"23","author":"HT Borno","year":"2018","unstructured":"Borno HT, Zhang L, Siegel A, Chang E, Ryan CJ. At what cost to clinical trial enrollment? A retrospective study of patient travel burden in cancer clinical trials. Oncologist. 2018;23(10):1242\u20139. https:\/\/doi.org\/10.1634\/theoncologist.2017-0628. (Epub 2018 Apr 26. PMID: 29700209; PMCID: PMC6263122.).","journal-title":"Oncologist"},{"key":"4423_CR12","unstructured":"M\u00e1s Datos C\u00e1ncer. Modelo integrado y global de conocimiento en c\u00e1ncer: informe de resultados. Published January 2025. Accessed January 20, 2026. https:\/\/www.masdatoscancer.es\/wp-content\/uploads\/2025\/01\/Modelo_integrado_y_global_de_conocimiento_Informe_resultados.pdf"},{"key":"4423_CR13","unstructured":"M\u00e1s Datos C\u00e1ncer. Modelo integrado y global de conocimiento en c\u00e1ncer: informe metodol\u00f3gico. Published January 2025. Accessed January 20, 2026. https:\/\/www.masdatoscancer.es\/wp-content\/uploads\/2025\/01\/Modelo_integrado_y_global_de_conocimiento-Informe-Metodologia.pdf"},{"issue":"3","key":"4423_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12094-016-1535-8","volume":"19","author":"J Salvador","year":"2017","unstructured":"Salvador J, Aparicio J, Baron FJ, Garcia-Campelo R, Garcia-Carbonero R, Lianes P, et al. Equity, barriers and cancer disparities: study of the Spanish society of medical oncology on the access to oncologic drugs in the Spanish Regions. Clin Transl Oncol. 2017;19(3):341\u201356. https:\/\/doi.org\/10.1007\/s12094-016-1535-8. (Epub 2016 Aug 25. Erratum in: Clin Transl Oncol. 2017 Apr;19(4):525. doi: 10.1007\/s12094-017-1628-z.).","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"4423_CR15","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s12094-020-02366-y","volume":"22","author":"A Rodr\u00edguez-Lescure","year":"2020","unstructured":"Rodr\u00edguez-Lescure A, de la Pe\u00f1a FA, Aranda E, Calvo A, Felip E, Garrido P, et al. Study of the Spanish society of medical oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain. Clin Transl Oncol. 2020;22(12):2253\u201363. https:\/\/doi.org\/10.1007\/s12094-020-02366-y.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"4423_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12094-024-03583-5","volume":"27","author":"P Cerezuela-Fuentes","year":"2025","unstructured":"Cerezuela-Fuentes P, Gonzalez-Cao M, Puertolas T, Manzano JL, Maldonado C, Yelamos O, et al. Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis. Clin Transl Oncol. 2025;27(1):386\u201391. https:\/\/doi.org\/10.1007\/s12094-024-03583-5.","journal-title":"Clin Transl Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04423-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04423-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04423-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:02:15Z","timestamp":1792803735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04423-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["4423"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04423-4","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (analysis based on publicly available, aggregated data).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}